Evidence mapPaperPMID 39014246Full record

Observational studyInternational journal of obesity (2005)2024

Sex-differential testosterone response to long-term weight loss.

Malgorzata M Brzozowska, Dana Bliuc, Artur Mazur, Paul A Baldock, John A Eisman, Jerry R Greenfield, Jacqueline R Center

Erratum issuedAbstract readObservational Study
In one paragraph

Observational study in International journal of obesity (2005), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Observational
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Malgorzata M BrzozowskaGarvan institute of Medical Research, Darlinghurst, NSW, Australia. Malgorzata.Brzozowska@health.nsw.gov.au.ORCID 0000-0003-0700-7750
Dana BliucGarvan institute of Medical Research, Darlinghurst, NSW, Australia.
Artur MazurUniversity of Rzeszow, Faculty of Medicine, Rzeszow, Poland.
Paul A BaldockGarvan institute of Medical Research, Darlinghurst, NSW, Australia.
John A EismanGarvan institute of Medical Research, Darlinghurst, NSW, Australia.
Jerry R GreenfieldGarvan institute of Medical Research, Darlinghurst, NSW, Australia.
Jacqueline R CenterGarvan institute of Medical Research, Darlinghurst, NSW, Australia.ORCID 0000-0002-5278-4527

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesObesity-associated gonadal dysfunction is a common comorbidity in patients seeking weight loss interventions. We examined the incremental effect of weight loss on gonadal axes in men and women over 3 years. Changes in sex hormones were compared between dietary intervention (Diet) and bariatric procedures: Roux-en-Y gastric bypass (RYGB), sleeve gastrectomy (SG) and laparoscopic adjustable gastric banding (LAGB). Additional analysis assessed changes in corticotropic, somatotropic and thyroid axes after weight loss interventions.

methodsThis prospective, observational study included 61 adults with Body Mass Index >30 kg/m

resultsFor each 1 kg of weight lost, between baseline and 36 months, total testosterone increased by 0.6% (95% CI: 0.2%, 1.0%, p = 0.002) in males and decreased by 0.8% (95% CI: -1.4%, -0.3%, p = 0.003) in females. These changes remained statistically significant when controlled for age and for menopausal status in females. At 36 months, in comparison with Diet, RYGB women had lower total testosterone by 54% (95% CI: -90%, -17%, p = 0.004), reduced free androgen index (FAI) by 65% (95% CI; -114%, -17%, p = 0.009) while SG had reduced FAI by 39% (95% CI; -77%, 0%, p = 0.05). No such differences between groups were noted for male subjects. Adrenocorticotropic hormone declined by 0.3% (95% CI: 0.0, -0.5%, p = 0.05), insulin-like growth factor-1 increased by 0.4% (95% CI; 0.2%, 0.7%, p = 0.005), without such thyrotrophin change for each 1 kg of weight loss, for entire cohort, over 36 months.

conclusionsThe testosterone changes observed in this study were proportional to the amount of weight loss. In females, reduction in androgens was independent of age and menopausal status and more pronounced after bariatric procedures. This study finding warrants further clinical research to explore an impact of androgen reduction on functional and cognitive status in postmenopausal women. The observed changes in pituitary hormones may contribute to the metabolic benefits of bariatric surgery.

Indexed as

TestosteroneWeight LossAdultBariatric SurgeryFemaleGastric BypassHumansMaleMiddle AgedObesity, MorbidProspective StudiesSex FactorsTestosterone

Identifiers

PMID39014246
PMCPMC11420080

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.